Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
New Brain Cancer Therapy Discovered in Israel
Error: Contact form not found.
by JNS.org
Hebrew University Logo. Photo: Wikipedia
JNS.org– A postdoctoral fellow at Hebrew University Hadassah Medical School identified a genetic protein involved in the development of glioblastoma, a common and aggressive brain cancer.
Regina Golan-Gerstl’s discovery could help create new diagnosis and treatment options for more than 20,000 Americans diagnosed with brain cancer each year. The Israel Cancer Research Fund supported the research, which detected higher than normal levels in some protein genes within glioblastoma samples.
In a laboratory study, researchers injected mice with gliobastoma cells, causing the mice to develop large tumors. But when the researchers reduced the levels of the protein gene, hnRNP A2/B1, the mice developed small tumors or no tumors.
“These results suggest that hnRNP A2/B1 is… a gene that… probably directly contributes to glioblastoma development,” said Dr. Rotem Karni, whose laboratory was used in the discovery, according to Israel National News.
“Down-regulating hnRNP A2/B1 levels in glioblastoma cells should be considered as a new strategy for glioblastoma therapy,” Karni said.
